| 摘要 |
FIELD: chemistry. ^ SUBSTANCE: present group of inventions refers to medicine, namely to ophthalmology, and involves therapy of eye diseases caused by nonmalignant neovascularisation, and also a medical product and pharmaceutical compositions containing prodrug combretastatin A4. ^ EFFECT: inventions provide effective therapy ensured with ability of prodrug combretastatin A4 to bind tubulin thereby preventing pathological vessel proliferation. ^ 29 cl, 12 tbl, 5 dwg, 8 ex |
